Longduoduo (LDDD) Income from Non-Controlling Interests (2021 - 2026)
Longduoduo (LDDD) posted quarterly Income from Non-Controlling Interests of -$22968.0 for Q1 2026, down 111.22% year-over-year from $204716.4 in Q1 2025, and down 45.83% quarter-over-quarter from -$15750.0 in Q4 2025.
Longduoduo (LDDD) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Longduoduo's Income from Non-Controlling Interests history runs 6 years deep, the most recent figure standing at -$22968.0 for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 111.22% year-over-year to -$22968.0; the TTM figure through Mar 2026 stood at -$54977.0 (down 164.36% YoY), while the FY2025 annual figure was $31825.0, down 70.49% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at -$22968.0, down from -$15750.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $157964.0 in Q2 2023, with the low at -$7.4 million in Q2 2022.
- The 5-year median for Income from Non-Controlling Interests is $574.0 (2024), against an average of -$425199.7.
- The sharpest annual moves came in 2023 and 2025: Income from Non-Controlling Interests jumped 276.04% in 2023, then sank 3514.46% in 2025.
- Longduoduo's Income from Non-Controlling Interests stood at -$19237.0 in 2022, then surged by 276.04% to $33865.0 in 2023, then increased by 14.26% to $38695.0 in 2024, then plunged by 140.7% to -$15750.0 in 2025, then slumped by 45.83% to -$22968.0 in 2026.
- Business Quant data shows LDDD's Income from Non-Controlling Interests at -$22968.0 in Q1 2026, -$15750.0 in Q4 2025, and -$19599.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 14.00 Mn |
| 10 | Longduoduo | 15.31 Mn | 14.14 Mn | 184,055.00 | -22,968.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,968.00 |
| Dec 31, 2025 | -15,750.00 |
| Sep 30, 2025 | -19,599.00 |
| Jun 30, 2025 | 3,340.00 |
| Mar 31, 2025 | -10,874.00 |
| Dec 31, 2024 | 38,695.00 |
| Sep 30, 2024 | 574.00 |
| Jun 30, 2024 | 57,023.00 |
| Mar 31, 2024 | 6,344.00 |
| Dec 31, 2023 | 33,865.00 |
| Sep 30, 2023 | 10,527.00 |
| Jun 30, 2023 | 157,964.00 |
| Mar 31, 2023 | -40,501.00 |
| Dec 31, 2022 | -19,237.00 |
| Sep 30, 2022 | -28,018.00 |
| Jun 30, 2022 | -7.38 Mn |
| Mar 31, 2022 | 3,544.00 |
| Dec 31, 2021 | -15,486.00 |
| Sep 30, 2021 | -26,297.00 |